+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Chronic Heart Failure Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767579
  • Report
  • 475 pages
  • VPA Research
UP TO OFF
until Dec 31st 2019
1 of 3

FEATURED COMPANIES

  • Amgen Inc
  • AstraZeneca Plc
  • Bayer AG
  • Cytokinetics Inc
  • Galenica Ltd
  • GlaxoSmithKline Plc
  • MORE
The global clinical trial report- “2019 Chronic Heart Failure Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Chronic Heart Failure. It presents in-depth analysis of Chronic Heart Failure clinical trials across markets and companies. The research work is for providing complete understanding into trends in Chronic Heart Failure.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Chronic Heart Failure clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Chronic Heart Failure

The research work is prepared through extensive and continuous research on Chronic Heart Failure trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Chronic Heart Failure patients are identified
  • The report includes panorama of Chronic Heart Failure clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Chronic Heart Failure clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Amgen Inc
  • AstraZeneca Plc
  • Bayer AG
  • Cytokinetics Inc
  • Galenica Ltd
  • GlaxoSmithKline Plc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Chronic Heart Failure Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Chronic Heart Failure Clinical Trials by Region
2.2.2 Average Enrollment of Chronic Heart Failure Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Chronic Heart Failure Treatment, 2019

3. Region wise Chronic Heart Failure Clinical Trials
3.1 Asia Pacific Chronic Heart Failure Clinical Trials by Country
3.2 Europe Chronic Heart Failure Clinical Trials by Country
3.3 North America Chronic Heart Failure Clinical Trials by Country
3.4 Middle East and Africa Chronic Heart Failure Clinical Trials by Country
3.5 South and Central America Chronic Heart Failure Clinical Trials by Country

4. Chronic Heart Failure Clinical Trial Trends
4.1 Start Year wise Chronic Heart Failure Clinical Trials
4.2 Phase wise Chronic Heart Failure Clinical Trials
4.3 Trial Status wise Chronic Heart Failure Clinical Trials
4.4 Trial Type wise Chronic Heart Failure Clinical Trials

5. Chronic Heart Failure Average Enrollment Trends
5.1 Average Enrollment in Chronic Heart Failure Trials by Year
5.2 Average Enrollment in Chronic Heart Failure Trials by Phase
5.3 Average Enrollment in Chronic Heart Failure Trials by Status
5.4 Average Enrollment in Chronic Heart Failure Trials by Type of Trial

6. Companies Participating in Chronic Heart Failure Clinical Trials
6.1 Chronic Heart Failure Trials by Sponsor Type
6.2 Chronic Heart Failure Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Chronic Heart Failure Trials- Phase 1
7.2 Chronic Heart Failure Trials- Phase 2
7.3 Chronic Heart Failure Trials- Phase 3
7.4 Chronic Heart Failure Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Chronic Heart Failure Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Chronic Heart Failure Clinical Trials and Enrolment
Figure 5: Europe - Country wise Chronic Heart Failure Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Chronic Heart Failure Clinical Trials and Enrolment
Figure 7: North America - Country wise Chronic Heart Failure Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Chronic Heart Failure Clinical Trials and Enrolment
Figure 9: Chronic Heart Failure Clinical Trials by Phase
Figure 10: Chronic Heart Failure Clinical Trials by Trial Status
Figure 11: Chronic Heart Failure Clinical Trials by Type
Figure 12: Chronic Heart Failure Clinical Trials by Sponsor Type
Figure 13: Chronic Heart Failure Clinical Trials by Leading Sponsors
Figure 14: Chronic Heart Failure Average Enrollment by Phase
Figure 15: Chronic Heart Failure Average Enrollment by Trial Status
Figure 16: Chronic Heart Failure Average Enrollment by Type
Figure 17: Chronic Heart Failure- Average Enrolment by Type of Sponsors
Figure 18: Chronic Heart Failure- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Chronic Heart Failure Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Chronic Heart Failure Clinical Trials and Enrolment
Table 5: Europe - Country wise Chronic Heart Failure Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Chronic Heart Failure Clinical Trials and Enrolment
Table 7: North America - Country wise Chronic Heart Failure Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Chronic Heart Failure Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Chronic Heart Failure Average Enrollment by Phase
Table 15: Chronic Heart Failure Average Enrollment by Trial Status
Table 16: Chronic Heart Failure Average Enrollment by Type
Table 17: Chronic Heart Failure- Average Enrolment by Type of Sponsors
Table 18: Chronic Heart Failure- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Amgen Inc
  • AstraZeneca Plc
  • Bayer AG
  • Cytokinetics Inc
  • Galenica Ltd
  • GlaxoSmithKline Plc
  • Les Laboratoires Servier SAS
  • Novartis AG
  • Orion Oyj
  • Zensun (Shanghai) Sci & Tech Co Ltd
Note: Product cover images may vary from those shown
Adroll
adroll